Cargando…

Formulation Considerations for the Management of Dry Eye Disease

Dry eye disease (DED) is one of the most common ocular surface disorders characterised by a deficiency in quality and/or quantity of the tear fluid. Due to its multifactorial nature involving several inter-related underlying pathologies, it can rapidly accelerate to become a chronic refractory condi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Agarwal, Priyanka, Craig, Jennifer P., Rupenthal, Ilva D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7913303/ https://www.ncbi.nlm.nih.gov/pubmed/33546193 http://dx.doi.org/10.3390/pharmaceutics13020207

Ejemplares similares

NLRP3 Inflammasome as a Potential Therapeutic Target in Dry Eye Disease
por: Zhuang, Dian, et al.
Publicado: (2023)

Formulation Development and Evaluation of the Therapeutic Efficacy of Brinzolamide Containing Nanoemulsions
por: Mahboobian, Mohammad Mehdi, et al.
Publicado: (2017)

Preparation and Characterisation of a Cyclodextrin-Complexed Mānuka Honey Microemulsion for Eyelid Application
por: Rupenthal, Ilva D., et al.
Publicado: (2022)

Randomised masked trial of the clinical safety and tolerability of MGO Manuka Honey eye cream for the management of blepharitis
por: Craig, Jennifer P, et al.
Publicado: (2017)

Dry Eye Disease: Consideration for Women's Health
por: Matossian, Cynthia, et al.
Publicado: (2019)

Trends in Dry Eye Disease Management Worldwide
por: Hantera, Mohamed Mostafa
Publicado: (2021)

Current Management and Treatment of Dry Eye Disease
por: Şimşek, Cem, et al.
Publicado: (2018)

Preclinical development of MGO Manuka Honey microemulsion for blepharitis management
por: Craig, Jennifer P, et al.
Publicado: (2017)

Intracellular oligonucleotide delivery using the cell penetrating peptide Xentry
por: Coutinho, Frazer P., et al.
Publicado: (2018)

Keratoprosthesis in dry eye disease
por: Sharma, Supriya, et al.
Publicado: (2023)

Differential Action of Connexin Hemichannel and Pannexin Channel Therapeutics for Potential Treatment of Retinal Diseases
por: Mat Nor, Mohd N., et al.
Publicado: (2021)

Personalized Management of Dry Eye Disease: Beyond Artificial Tears
por: Matossian, Cynthia, et al.
Publicado: (2022)

Development of a novel stability indicating RP-HPLC method for quantification of Connexin43 mimetic peptide and determination of its degradation kinetics in biological fluids
por: Bisht, Rohit, et al.
Publicado: (2017)

Characterization of Zinc Oxide Nanoparticle Cross-Linked Collagen Hydrogels
por: Agban, Yosra, et al.
Publicado: (2020)

Dry eye module – An application intelligence platform for diagnosing and monitoring dry eye disease
por: Iyer, Geetha, et al.
Publicado: (2023)

Development of Solid Lipid Nanoparticles as Dry Powder: Characterization and Formulation Considerations
por: Santonocito, Debora, et al.
Publicado: (2023)

Diagnostic Procedures and Management of Dry Eye
por: Kaštelan, Snježana, et al.
Publicado: (2013)

Xentry-Gap19 inhibits Connexin43 hemichannel opening especially during hypoxic injury
por: Coutinho, Frazer P., et al.
Publicado: (2020)

Relevance of Lipid-Based Products in the Management of Dry Eye Disease
por: Garrigue, Jean-Sébastien, et al.
Publicado: (2017)

Comprehensive Grading System for Experimental Autoimmune Uveitis in Mice
por: Shome, Avik, et al.
Publicado: (2023)

Glaucoma and Dry Eye Disease: Opportunity to Assess and Treat
por: Nijm, Lisa M, et al.
Publicado: (2023)

Artificial Tears: Biological Role of Their Ingredients in the Management of Dry Eye Disease
por: Labetoulle, Marc, et al.
Publicado: (2022)

Pulsed Light Therapy in the Management of Dry Eye Disease: Current Perspectives
por: Barbosa Ribeiro, Bruno, et al.
Publicado: (2022)

A Review of the Mechanism of Action of Cyclosporine A: The Role of Cyclosporine A in Dry Eye Disease and Recent Formulation Developments
por: Periman, Laura M, et al.
Publicado: (2020)

Correlation between the progression of diabetic retinopathy and inflammasome biomarkers in vitreous and serum – a systematic review
por: Kuo, Charisse Y. J., et al.
Publicado: (2022)

Dry Eye Management: Targeting the Ocular Surface Microenvironment
por: Zhang, Xiaobo, et al.
Publicado: (2017)

Role of tear film biomarkers in the diagnosis and management of dry eye disease
por: Fong, Pak Yui, et al.
Publicado: (2019)

Practical guidance for the use of cyclosporine ophthalmic solutions in the management of dry eye disease
por: de Oliveira, Rodrigo Carlos, et al.
Publicado: (2019)

The Management of Dry Eye Disease: Proceedings of Italian Dry Eye Consensus Group Using the Delphi Method
por: Aragona, Pasquale, et al.
Publicado: (2022)

Expert opinion in the management of aqueous Deficient Dry Eye Disease (DED)
por: Sy, Aileen, et al.
Publicado: (2015)

Propylene Glycol and Hydroxypropyl Guar Nanoemulsion - Safe and Effective Lubricant Eye Drops in the Management of Dry Eye Disease
por: Srinivasan, Sruthi, et al.
Publicado: (2022)

Dry Eye: an Inflammatory Ocular Disease
por: Hessen, Michelle, et al.
Publicado: (2014)

Lifitegrast: a novel drug for patients with dry eye disease
por: Haber, Stacy L., et al.
Publicado: (2019)

Tonabersat Inhibits Connexin43 Hemichannel Opening and Inflammasome Activation in an In Vitro Retinal Epithelial Cell Model of Diabetic Retinopathy
por: Lyon, Heather, et al.
Publicado: (2020)

Hormones and dry eye disease
por: Gorimanipalli, Bhavya, et al.
Publicado: (2023)

Hyaluronic acid in the treatment of dry eye disease
por: Hynnekleiv, Leif, et al.
Publicado: (2022)

Diagnosis of dry eye disease and emerging technologies
por: Zeev, Maya Salomon-Ben, et al.
Publicado: (2014)

Dry Eye Disease in Routine Rheumatology Practice
por: Ziaragkali, Sevastiani, et al.
Publicado: (2018)

The effect of intravitreal injections on dry eye, and proposed management strategies
por: Laude, Augustinus, et al.
Publicado: (2017)

Comprehensive Review of the Literature on Existing Punctal Plugs for the Management of Dry Eye Disease
por: Jehangir, Naz, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_ghqf912to12nnn56476f754k2d